• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过去40年老年小细胞肺癌患者的流行病学变化;一项监测、流行病学和最终结果(SEER)数据库分析

Changing epidemiology of elderly small cell lung cancer patients over the last 40 years; a SEER database analysis.

作者信息

Abdel-Rahman Omar

机构信息

Clinical Oncology department, faculty of medicine, Ain Shams University, Cairo, Egypt.

出版信息

Clin Respir J. 2018 Mar;12(3):1093-1099. doi: 10.1111/crj.12632. Epub 2017 Apr 12.

DOI:10.1111/crj.12632
PMID:28371208
Abstract

BACKGROUND

Small cell lung cancer (SCLC) is a distinct clinical and pathological entity within the spectrum of lung cancer. It was observed that the relative age distribution of the disease changed over years.

METHODS

Surveillance, epidemiology, and end results (SEER) database (1973-2013) was utilized to determine the incidence, presentation and treatment outcomes of elderly patients (>70 years) with SCLC. Join point regression analysis was then conducted to analyze age-adjusted trends in incidence for the elderly as well as the whole SCLC population. Survival analysis was conducted through Kaplan-Meier analysis. Clinicopathological characteristics and survival outcomes were compared between patients diagnosed at 70-79 years old and those older than 80 years old (octogenarian group).

RESULTS

The proportion of elderly patients among all cases of SCLC increased from 23% in 1975 to 44% in 2010. Moreover, the proportion of elderly female patients among all cases of elderly SCLC increased from 25% in 1975 to 49% in 2010. When categorizing patients into four subgroups "70-74," "75-79," "80-84," and "85+", there was a trend toward a lower cancer-specific survival with increasing age (P < .0001). A limited improvement in 5 year survival was observed during the study period and it is less apparent as the age increases.

CONCLUSION

The proportion of elderly patients among all cases of SCLC has increased over the past 40 years. Further studies are needed to better select appropriate treatments for this subset of patients.

摘要

背景

小细胞肺癌(SCLC)是肺癌谱系中一种独特的临床和病理实体。据观察,该疾病的相对年龄分布多年来有所变化。

方法

利用监测、流行病学和最终结果(SEER)数据库(1973 - 2013年)来确定老年(>70岁)小细胞肺癌患者的发病率、临床表现和治疗结果。然后进行连接点回归分析,以分析老年患者以及整个小细胞肺癌人群发病率的年龄调整趋势。通过Kaplan - Meier分析进行生存分析。比较70 - 79岁诊断的患者与80岁以上(八十岁以上组)患者的临床病理特征和生存结果。

结果

在所有小细胞肺癌病例中,老年患者的比例从1975年的23%增加到2010年的44%。此外,在所有老年小细胞肺癌病例中,老年女性患者的比例从1975年的25%增加到2010年的49%。将患者分为“70 - 74”、“75 - 79”、“80 - 84”和“85岁以上”四个亚组时,癌症特异性生存率有随年龄增加而降低的趋势(P <.0001)。在研究期间观察到5年生存率有有限的改善,且随着年龄增加不太明显。

结论

在过去40年中,所有小细胞肺癌病例中老年患者的比例有所增加。需要进一步研究以更好地为这部分患者选择合适的治疗方法。

相似文献

1
Changing epidemiology of elderly small cell lung cancer patients over the last 40 years; a SEER database analysis.过去40年老年小细胞肺癌患者的流行病学变化;一项监测、流行病学和最终结果(SEER)数据库分析
Clin Respir J. 2018 Mar;12(3):1093-1099. doi: 10.1111/crj.12632. Epub 2017 Apr 12.
2
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.过去30年美国小细胞肺癌流行病学的变化:监测、流行病学和最终结果数据库分析
J Clin Oncol. 2006 Oct 1;24(28):4539-44. doi: 10.1200/JCO.2005.04.4859.
3
Malignant Pleural Effusion at Presentation in Patients with Small-Cell Lung Cancer.小细胞肺癌患者初次就诊时出现恶性胸腔积液。
Respiration. 2019;98(3):198-202. doi: 10.1159/000499372. Epub 2019 May 23.
4
Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer.Ⅰ期小细胞肺癌手术治疗作用的监测、流行病学和最终结果评估。
J Thorac Oncol. 2010 Feb;5(2):215-9. doi: 10.1097/JTO.0b013e3181cd3208.
5
Effects of surgery on survival of elderly patients with stage I small-cell lung cancer: analysis of the SEER database.手术对 I 期老年小细胞肺癌患者生存的影响:SEER 数据库分析。
J Cancer Res Clin Oncol. 2019 Sep;145(9):2397-2404. doi: 10.1007/s00432-019-02976-2. Epub 2019 Jul 13.
6
Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database.老年患者的肺癌:监测、流行病学和最终结果数据库分析
J Clin Oncol. 2007 Dec 10;25(35):5570-7. doi: 10.1200/JCO.2007.12.5435.
7
The changing landscape of small cell lung cancer.小细胞肺癌的变迁。
Cancer. 2024 Jul 15;130(14):2453-2461. doi: 10.1002/cncr.35281. Epub 2024 Mar 12.
8
Better cancer specific survival in young small cell lung cancer patients especially with AJCC stage III.年轻的小细胞肺癌患者,尤其是美国癌症联合委员会(AJCC)III期患者,具有更好的癌症特异性生存率。
Oncotarget. 2017 May 23;8(21):34923-34934. doi: 10.18632/oncotarget.16823.
9
Feasibility and validity of The Health Improvement Network database of primary care electronic health records to identify and characterise patients with small cell lung cancer in the United Kingdom.利用初级保健电子健康记录的健康改善网络数据库在英国识别和描述小细胞肺癌患者的可行性和有效性。
BMC Cancer. 2019 Jan 21;19(1):91. doi: 10.1186/s12885-019-5305-1.
10
Validation of the AJCC 8th lung cancer staging system among patients with small cell lung cancer.AJCC 第 8 版肺癌分期系统在小细胞肺癌患者中的验证。
Clin Transl Oncol. 2018 Apr;20(4):550-556. doi: 10.1007/s12094-017-1739-6. Epub 2017 Aug 14.

引用本文的文献

1
[Advances in Radiotherapy for Extensive-stage Small Cell Lung Cancer 
in the Era of Immunotherapy].[免疫治疗时代广泛期小细胞肺癌的放射治疗进展]
Zhongguo Fei Ai Za Zhi. 2025 May 20;28(5):353-362. doi: 10.3779/j.issn.1009-3419.2025.102.20.
2
Real-world data on immunotherapy combined with chemotherapy in elderly patients with extensive-stage small cell lung cancer.老年广泛期小细胞肺癌患者免疫治疗联合化疗的真实世界数据。
BMC Cancer. 2025 Mar 14;25(1):467. doi: 10.1186/s12885-025-13880-z.
3
Acceptance of Illness and Health Behaviours of Patients with End-Stage Renal Disease Treated with Haemodialysis: A Single-Centre Study.
接受血液透析治疗的终末期肾病患者对疾病的认知及健康行为:一项单中心研究
Healthcare (Basel). 2024 Dec 19;12(24):2562. doi: 10.3390/healthcare12242562.
4
Implications for practice: phase II/III trial of carboplatin and irinotecan for elderly patients with extensive-stage small-cell lung cancer in Japan.实践意义:日本针对广泛期小细胞肺癌老年患者开展的卡铂和伊立替康II/III期试验
J Thorac Dis. 2024 Sep 30;16(9):6342-6346. doi: 10.21037/jtd-24-279. Epub 2024 Sep 23.
5
Predictive model for totally implanted venous access ports‑related long‑term complications in patients with lung cancer.肺癌患者完全植入式静脉输液港相关长期并发症的预测模型
Oncol Lett. 2024 May 15;28(1):326. doi: 10.3892/ol.2024.14459. eCollection 2024 Jul.
6
Radiotherapy for extensive-stage small-cell lung cancer in the immunotherapy era.免疫治疗时代广泛期小细胞肺癌的放射治疗。
Front Immunol. 2023 Aug 28;14:1132482. doi: 10.3389/fimmu.2023.1132482. eCollection 2023.
7
Surgery radiotherapy in a population-based cohort of elderly patients with early-stage small-cell lung cancer: an IPTW propensity-score analysis.基于人群队列的老年早期小细胞肺癌患者手术与放疗的倾向评分逆概率加权分析
J Thorac Dis. 2023 May 30;15(5):2769-2778. doi: 10.21037/jtd-23-428. Epub 2023 May 9.
8
Targeted Therapies in Small Cell Lung Cancer: From Old Failures to Novel Therapeutic Strategies.小细胞肺癌的靶向治疗:从旧的失败到新的治疗策略。
Int J Mol Sci. 2023 May 17;24(10):8883. doi: 10.3390/ijms24108883.
9
Clinicopathological Features and First-Line Treatment Outcomes of Geriatric Patients With Extensive-Stage Small Cell Lung Cancer: A Multicenter Study.广泛期小细胞肺癌老年患者的临床病理特征及一线治疗结局:一项多中心研究
Cureus. 2023 Mar 2;15(3):e35710. doi: 10.7759/cureus.35710. eCollection 2023 Mar.
10
The role of surgery in older patients with T1-2N0M0 small cell lung cancer: A propensity score matching analysis.手术在T1-2N0M0期老年小细胞肺癌患者中的作用:一项倾向评分匹配分析。
Front Oncol. 2022 Sep 30;12:958187. doi: 10.3389/fonc.2022.958187. eCollection 2022.